Aldeyra Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trading Halts

Aldeyra Therapeutics (ALDX) Prices 10M Share IPO at $12.50/ShApril 29, 2021 5:44 AM Aldeyra Therapeutics (ALDX) Achieves Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE Clinical Trial of Reproxalap in Allergic ConjunctivitisApril 27, 2021 7:03 AM Aldeyra Therapeutics (ALDX) Halted for NewsApril 27, 2021 7:02 AM Aldeyra Therapeutics Achieves Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE Clinical Trial of Reproxalap in Allergic ConjunctivitisApril 27, 2021 7:00 AM